- Recommendation ID
- TA467/2
- Question
NICE recommended that further research should be designed to generate robust evidence of the clinical- and cost-effectiveness of Holoclar for treating both eyes in people with bilateral limbal stem cell deficiency after eye burns if they do not have enough tissue for a conjunctival limbal autograft. The study should recruit people with bilateral disease and evaluate the effectiveness of treatment in both eyes. Outcomes should include transplant success and assessments of health-related quality of life using a generic preference-based measure.
- Any explanatory notes
(if applicable) N/A
Source guidance details
- Comes from guidance
- Holoclar for treating limbal stem cell deficiency after eye burns
- Number
- TA467
- Date issued
- August 2017
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/08/2017 |